Feedback / Questions
astegolimab (RG 6149) - Amgen, Roche
Astegolimab: NME submission in US for COPD in 2025
(Roche)
-
Oct 23, 2025 -
Q3 2025 Results: Regulatory submission in EU for COPD in 2025
EMA filing • FDA filing
•
Chronic Obstructive Pulmonary Disease • Immunology
https://assets.roche.com/f/176343/x/a22e1c7d2f/irp251023.pdf
Oct 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious